跳至主要内容
临床试验/ITMCTR2100004714
ITMCTR2100004714招募中1 期

Clinical Observation of Xiakucao Oral Liquid in Treating Graves Disease

Guang'anmen Hospital, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • 1. Aged between 18 and 65 years;
  • 2. According to the diagnostic criteria of Graves disease who diagnosed with Graves disease and with goiter;
  • 3. Who have signed informed consent.

排除标准

  • 1. Patients with thyrotoxicosis caused by causes other than Graves' disease, such as nodular toxic goiter and autonomous high-functioning thyroid adenoma;
  • 2. Patients with active thyroid eye disease;
  • 3. Patients with thyroid cancer and other malignant tumors;
  • 4. Patients with abnormal liver and kidney function (ALT or AST > 2 times the upper limit of normal, Scr > upper limit of normal) and other serious diseases of the system;
  • 5. Patients with a history of radioactive 131I or surgical treatment;
  • 6. Women with pregnancy or lactation;
  • 7. Have used antithyroid drugs or other drugs that may affect this test in the past two weeks;
  • 8. Patients with hyperthyroidism crisis or hyperthyroidism with myasthenia gravis;
  • 9. Those who are known to be allergic to the test drug or its components;
  • 10. Researchers consider that they are not suitable for selection.

研究者

相似试验